The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains

J. D. Eicher, C. M. Stein, F. Deng, A. A. Ciesla, N. R. Powers, R. Boada, Shelley D Smith, B. F. Pennington, S. K. Iyengar, B. A. Lewis, J. R. Gruen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A major milestone of child development is the acquisition and use of speech and language. Communication disorders, including speech sound disorder (SSD), can impair a child's academic, social and behavioral development. Speech sound disorder is a complex, polygenic trait with a substantial genetic component. However, specific genes that contribute to SSD remain largely unknown. To identify associated genes, we assessed the association of the DYX2 dyslexia risk locus and markers in neurochemical signaling genes (e.g., nicotinic and dopaminergic) with SSD and related endophenotypes. We first performed separate primary associations in two independent samples - Cleveland SSD (210 affected and 257 unaffected individuals in 127 families) and Denver SSD (113 affected individuals and 106 unaffected individuals in 85 families) - and then combined results by meta-analysis. DYX2 markers, specifically those in the 3′ untranslated region of DCDC2 (P = 1.43 × 10<sup>-4</sup>), showed the strongest associations with phonological awareness. We also observed suggestive associations of dopaminergic-related genes ANKK1 (P = 1.02 × 10<sup>-2</sup>) and DRD2 (P = 9.22 × 10<sup>-3</sup>) and nicotinic-related genes CHRNA3 (P = 2.51 × 10<sup>-3</sup>) and BDNF (P = 8.14 × 10<sup>-3</sup>) with case-control status and articulation. Our results further implicate variation in putative regulatory regions in the DYX2 locus, particularly in DCDC2, influencing language and cognitive traits. The results also support previous studies implicating variation in dopaminergic and nicotinic neural signaling influencing human communication and cognitive development. Our findings expand the literature showing genetic factors (e.g., DYX2) contributing to multiple related, yet distinct neurocognitive domains (e.g., dyslexia, language impairment, and SSD). How these factors interactively yield different neurocognitive and language-related outcomes remains to be elucidated.

Original languageEnglish (US)
Pages (from-to)377-385
Number of pages9
JournalGenes, Brain and Behavior
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Genes
Language
Dyslexia
Multifactorial Inheritance
Communication Disorders
Endophenotypes
Nucleic Acid Regulatory Sequences
Brain-Derived Neurotrophic Factor
3' Untranslated Regions
Child Development
Speech Sound Disorder
Meta-Analysis
Communication

Keywords

  • DCDC2
  • Dopaminergic
  • DYX2
  • Nicotinic
  • Speech sound disorder

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Genetics
  • Neurology

Cite this

Eicher, J. D., Stein, C. M., Deng, F., Ciesla, A. A., Powers, N. R., Boada, R., ... Gruen, J. R. (2015). The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains. Genes, Brain and Behavior, 14(4), 377-385. https://doi.org/10.1111/gbb.12214

The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains. / Eicher, J. D.; Stein, C. M.; Deng, F.; Ciesla, A. A.; Powers, N. R.; Boada, R.; Smith, Shelley D; Pennington, B. F.; Iyengar, S. K.; Lewis, B. A.; Gruen, J. R.

In: Genes, Brain and Behavior, Vol. 14, No. 4, 01.04.2015, p. 377-385.

Research output: Contribution to journalArticle

Eicher, JD, Stein, CM, Deng, F, Ciesla, AA, Powers, NR, Boada, R, Smith, SD, Pennington, BF, Iyengar, SK, Lewis, BA & Gruen, JR 2015, 'The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains', Genes, Brain and Behavior, vol. 14, no. 4, pp. 377-385. https://doi.org/10.1111/gbb.12214
Eicher, J. D. ; Stein, C. M. ; Deng, F. ; Ciesla, A. A. ; Powers, N. R. ; Boada, R. ; Smith, Shelley D ; Pennington, B. F. ; Iyengar, S. K. ; Lewis, B. A. ; Gruen, J. R. / The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains. In: Genes, Brain and Behavior. 2015 ; Vol. 14, No. 4. pp. 377-385.
@article{b65daa0637564746a322e2a2ac6ba5f6,
title = "The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains",
abstract = "A major milestone of child development is the acquisition and use of speech and language. Communication disorders, including speech sound disorder (SSD), can impair a child's academic, social and behavioral development. Speech sound disorder is a complex, polygenic trait with a substantial genetic component. However, specific genes that contribute to SSD remain largely unknown. To identify associated genes, we assessed the association of the DYX2 dyslexia risk locus and markers in neurochemical signaling genes (e.g., nicotinic and dopaminergic) with SSD and related endophenotypes. We first performed separate primary associations in two independent samples - Cleveland SSD (210 affected and 257 unaffected individuals in 127 families) and Denver SSD (113 affected individuals and 106 unaffected individuals in 85 families) - and then combined results by meta-analysis. DYX2 markers, specifically those in the 3′ untranslated region of DCDC2 (P = 1.43 × 10-4), showed the strongest associations with phonological awareness. We also observed suggestive associations of dopaminergic-related genes ANKK1 (P = 1.02 × 10-2) and DRD2 (P = 9.22 × 10-3) and nicotinic-related genes CHRNA3 (P = 2.51 × 10-3) and BDNF (P = 8.14 × 10-3) with case-control status and articulation. Our results further implicate variation in putative regulatory regions in the DYX2 locus, particularly in DCDC2, influencing language and cognitive traits. The results also support previous studies implicating variation in dopaminergic and nicotinic neural signaling influencing human communication and cognitive development. Our findings expand the literature showing genetic factors (e.g., DYX2) contributing to multiple related, yet distinct neurocognitive domains (e.g., dyslexia, language impairment, and SSD). How these factors interactively yield different neurocognitive and language-related outcomes remains to be elucidated.",
keywords = "DCDC2, Dopaminergic, DYX2, Nicotinic, Speech sound disorder",
author = "Eicher, {J. D.} and Stein, {C. M.} and F. Deng and Ciesla, {A. A.} and Powers, {N. R.} and R. Boada and Smith, {Shelley D} and Pennington, {B. F.} and Iyengar, {S. K.} and Lewis, {B. A.} and Gruen, {J. R.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/gbb.12214",
language = "English (US)",
volume = "14",
pages = "377--385",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains

AU - Eicher, J. D.

AU - Stein, C. M.

AU - Deng, F.

AU - Ciesla, A. A.

AU - Powers, N. R.

AU - Boada, R.

AU - Smith, Shelley D

AU - Pennington, B. F.

AU - Iyengar, S. K.

AU - Lewis, B. A.

AU - Gruen, J. R.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - A major milestone of child development is the acquisition and use of speech and language. Communication disorders, including speech sound disorder (SSD), can impair a child's academic, social and behavioral development. Speech sound disorder is a complex, polygenic trait with a substantial genetic component. However, specific genes that contribute to SSD remain largely unknown. To identify associated genes, we assessed the association of the DYX2 dyslexia risk locus and markers in neurochemical signaling genes (e.g., nicotinic and dopaminergic) with SSD and related endophenotypes. We first performed separate primary associations in two independent samples - Cleveland SSD (210 affected and 257 unaffected individuals in 127 families) and Denver SSD (113 affected individuals and 106 unaffected individuals in 85 families) - and then combined results by meta-analysis. DYX2 markers, specifically those in the 3′ untranslated region of DCDC2 (P = 1.43 × 10-4), showed the strongest associations with phonological awareness. We also observed suggestive associations of dopaminergic-related genes ANKK1 (P = 1.02 × 10-2) and DRD2 (P = 9.22 × 10-3) and nicotinic-related genes CHRNA3 (P = 2.51 × 10-3) and BDNF (P = 8.14 × 10-3) with case-control status and articulation. Our results further implicate variation in putative regulatory regions in the DYX2 locus, particularly in DCDC2, influencing language and cognitive traits. The results also support previous studies implicating variation in dopaminergic and nicotinic neural signaling influencing human communication and cognitive development. Our findings expand the literature showing genetic factors (e.g., DYX2) contributing to multiple related, yet distinct neurocognitive domains (e.g., dyslexia, language impairment, and SSD). How these factors interactively yield different neurocognitive and language-related outcomes remains to be elucidated.

AB - A major milestone of child development is the acquisition and use of speech and language. Communication disorders, including speech sound disorder (SSD), can impair a child's academic, social and behavioral development. Speech sound disorder is a complex, polygenic trait with a substantial genetic component. However, specific genes that contribute to SSD remain largely unknown. To identify associated genes, we assessed the association of the DYX2 dyslexia risk locus and markers in neurochemical signaling genes (e.g., nicotinic and dopaminergic) with SSD and related endophenotypes. We first performed separate primary associations in two independent samples - Cleveland SSD (210 affected and 257 unaffected individuals in 127 families) and Denver SSD (113 affected individuals and 106 unaffected individuals in 85 families) - and then combined results by meta-analysis. DYX2 markers, specifically those in the 3′ untranslated region of DCDC2 (P = 1.43 × 10-4), showed the strongest associations with phonological awareness. We also observed suggestive associations of dopaminergic-related genes ANKK1 (P = 1.02 × 10-2) and DRD2 (P = 9.22 × 10-3) and nicotinic-related genes CHRNA3 (P = 2.51 × 10-3) and BDNF (P = 8.14 × 10-3) with case-control status and articulation. Our results further implicate variation in putative regulatory regions in the DYX2 locus, particularly in DCDC2, influencing language and cognitive traits. The results also support previous studies implicating variation in dopaminergic and nicotinic neural signaling influencing human communication and cognitive development. Our findings expand the literature showing genetic factors (e.g., DYX2) contributing to multiple related, yet distinct neurocognitive domains (e.g., dyslexia, language impairment, and SSD). How these factors interactively yield different neurocognitive and language-related outcomes remains to be elucidated.

KW - DCDC2

KW - Dopaminergic

KW - DYX2

KW - Nicotinic

KW - Speech sound disorder

UR - http://www.scopus.com/inward/record.url?scp=84928268892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928268892&partnerID=8YFLogxK

U2 - 10.1111/gbb.12214

DO - 10.1111/gbb.12214

M3 - Article

VL - 14

SP - 377

EP - 385

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

IS - 4

ER -